Edition:
United Kingdom

Medigene AG (MDG1k.DE)

MDG1k.DE on Xetra

8.94EUR
4:35pm GMT
Change (% chg)

€0.19 (+2.11%)
Prev Close
€8.75
Open
€8.78
Day's High
€9.05
Day's Low
€8.65
Volume
76,201
Avg. Vol
127,458
52-wk High
€19.42
52-wk Low
€7.20

Chart for

About

Medigene AG is a Germany-based biotechnology company that develops treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. The Company focuses on the development of personalized T cell-based immunotherapies. It develops three platforms: T-cell receptor (TCR)-modi... (more)

Overall

Beta: 1.27
Market Cap(Mil.): €287.57
Shares Outstanding(Mil.): 22.30
Dividend: --
Yield (%): --

Financials

  MDG1k.DE Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -0.81 -- --
ROI: -15.86 8.92 14.45
ROE: -18.62 10.08 15.96

Earnings vs. Estimates